Press Releases

February 9 2016

Elements of the President’s budget proposal for 2017 directly threaten his Administration...

February 2 2016

BIO applauds the House of Representatives for approving the SEC Small Business Advocate Act (H.R...

December 16 2015

BIO today welcomed legislation to extend critical tax incentives that are important to...

December 2 2015

BIO supports legislation to follow up on the success of the JOBS Act

August 11 2015

BIO Investor Forum to be held October 20-21 in San Francisco, California...

May 21 2015

By making this tax credit permanent, companies conducting their development programs will be...

May 7 2015

Program will improve liquidity and enhance capital formation for emerging biotech companies

April 16 2015

BIO commends Senate Finance Committee Chairman Orrin Hatch (R-UT), Ranking Member Ron Wyden (D...

February 9 2015

Report shows increase in funding for rare diseases and decrease in funding for chronic...

September 25 2014

Washington, DC, September 25, 2014 – Today, the Biotechnology Industry...

September 17 2014

Legislation aimed at enhancing capital access and creating jobs

September 4 2014

Washington, D.C. (September 4, 2014) – The Biotechnology...

August 6 2014

Survey responses will help inform Prescription Drug User Fee Act VI negotiations

May 9 2014

Bill would strengthen, make permanent critical R&D tax credit

April 9 2014

The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing...

April 7 2014

The EXPIRE Act would extend tax credits that expired at the end of 2013, including...

February 12 2014

Bill would spur capital formation for small public companies

December 19 2013

More than 140 Companies Expected to Present Their Story to Top Public and...

November 13 2013

The Bill will spur capital formation for small public companies

November 6 2013

Bill will encourage investment in growing innovative companies

September 30 2013

NSF-funded companies focused on drug discovery, diagnostics and other platform technologies....

September 11 2013

Speakers will provide fresh insight, investment opportunities in biotech sector.

May 21 2013

CSBI encourages a tax code that promotes economic growth and creates jobs.

May 16 2013

H.R. 701 sets a deadline to complete rule-making on Regulation A reforms.

May 15 2013

H.R. 1952 will stimulate trading for small public companies.

January 8 2013

Small Business Innovation Research grants provide critical support for emerging biotech...

September 25 2012

Bill would stimulate capital formation for small biotech companies.

July 26 2012

The House Subcommittee on Capital Markets held a hearing entitled “The 10th Anniversary...

July 20 2012

New bill will update SEC filing status classifications to ease costly regulatory burdens...

June 6 2012

The report will be released at a Super Session, titled "International Leaders Share Their...

March 27 2012

The JOBS Act will incentivize and encourage capital formation for growing companies, and...

March 20 2012

Buzz of BIO voting available online.

March 8 2012

House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

March 6 2012

OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate...

January 18 2012

Fireside Chats to focus on biopharma R&D and corporate strategy.

December 19 2011

Extension of cellulosic biofuel tax credits now and eligibility for algae biofuels are needed...

December 16 2011

Grants will provide critical funding to small emerging biotechnology companies working on...

December 13 2011

Small Business Innovation Research (SBIR) grants provide critical funding for the development...

December 6 2011

Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO)...

November 16 2011

"The most important return on investment from this initiative would be the creation of...

October 13 2011

BIO President and CEO Jim Greenwood released the following statement on the Obama...

October 11 2011

BIO Investor Forum will be held October 25 – 26 in San Francisco, CA

...

October 6 2011

BIO Investor Forum will be held October 25 – 26 in San Francisco, CA 

September 19 2011

  The Biotechnology Industry Organization (BIO) today announced the preliminary set...

September 9 2011

BIO President and CEO Jim Greenwood released the following statement on President Obama’...

September 6 2011

The Biotechnology Industry Organization (BIO) announced the keynote speakers for the BIO India...

July 26 2011

BIO applauded Secretary of Agriculture Tom Vilsack’s announcement of four new BCAP project areas...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

April 7 2011

Today, the House Subcommittee on Healthcare and Technology will hold a hearing on The Creating...

February 14 2011

The study is expected to inform and improve communications between biotech executives,...

February 11 2011

BIO announces that President and CEO James C. Greenwood will ring the closing bell at The...

February 11 2011

According to a new survey of CEOs of small biotech firms that received Therapeutic Discovery...

February 9 2011

BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance...

January 20 2011

BIO thanks Secretary of Agriculture Tom Vilsack for his leadership on biofuels...

January 10 2011

Hosted by BIO, the exclusive partnering forum brings together U.S. and European drug...

January 3 2011

The 2011 BIO International Convention will highlight the latest trends and the newest...

December 11 2009

BIO commends the House of Representatives for including provisions intended to ease small...

June 26 2007

Today, the House Science and Technology Committee’s Technology and Innovation Subcommittee will...

June 6 2007

The changes proposed by the Securities and Exchange Commission (SEC) and the Public Companies...

April 18 2007

BIO reiterates support as Senate Small Business Committee considers changes.

February 28 2007

BIO thanks the Bush administration for taking dramatic new steps to transform biotech...

December 13 2006

BIO President and CEO Jim Greenwood today commented on reports that the Securities and Exchange...

September 20 2006

The Milken Institute study released today entitled “Mind-to-Market: A Global Analysis of...

May 30 2002

The Biotechnology Industry Organization’s (BIO) annual meeting, BIO 2002 in Toronto,...

Letters, Testimony & Comments

April 30 2015
On behalf of the Biotechnology Industry Organization Before the United States House of Representatives Committee on Financial Services, Subcommittee on Capital Markets and Government Sponsored Enterprises --- Legislative Proposals to Enhance Capital Formation and Reduce Regulatory Burdens
April 29 2014
Chairperson Mikulski, Ranking Member Shelby, Members of the Committee, thank you for the opportunity to provide you with written testimony on the extremely important topic of driving innovation through federal investments.
November 6 2013
On behalf of the BIO and its 1,100 members, I am writing in strong support of your Start-up Jobs and Innovation Act. I want to thank you for introducing this important legislation, which will spur investment in small biotech companies and other innovative businesses.
July 10 2013
A healthy public market is key to the success of the biotech industry, as growing innovators often turn to an IPO to fund late-stage clinical trials.
July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer of Vitae Pharmaceuticals, testified on behalf of BIO about the 10th anniversary of the Sarbanes-Oxley Act.

Press Releases

April 29 2016
Bill would enhance the voice of emerging companies at the SEC Washington, D.C. (April 29, 2016) – Today, the Biotechnology Innovation Organization (BIO) applauds Senators Heidi Heitkamp (D-ND), Dean Heller (R-NV) and Gary Peters (D-MI) for introducing the SEC Small Business Advocate Act, which would ensure that growing companies have a strong, independent voice at the Securities and Exchange Commission (SEC). 
February 9 2016
Elements of the President’s budget proposal for 2017 directly threaten his Administration’s goal of curing cancer through advances in precision medicine
February 2 2016
BIO applauds the House of Representatives for approving the SEC Small Business Advocate Act (H.R. 3784) and the Small Business Capital Formation Enhancement Act (H.R. 4168). These bills would enhance the role that small businesses play in the decision-making process at the Securities and Exchange Commission, ensuring that SEC policies support the growth of emerging biotech innovators.
December 16 2015
BIO today welcomed legislation to extend critical tax incentives that are important to biotechnology companies. The legislation would make permanent the important Research & Development Tax Credit.
December 2 2015
BIO supports legislation to follow up on the success of the JOBS Act